Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy

Antivir Ther. 2001 Sep;6(3):195-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Adult
  • Aged
  • Antiretroviral Therapy, Highly Active*
  • Drug Resistance, Viral
  • Female
  • HIV Reverse Transcriptase / genetics*
  • Humans
  • Lamivudine / therapeutic use*
  • Male
  • Middle Aged
  • Mutation*
  • Reverse Transcriptase Inhibitors / therapeutic use*

Substances

  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • HIV Reverse Transcriptase